Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?

Taha, Tarek; Tan, Wei Phin; Elshafei, Ahmed; Aminsharifi, Alireza; Given, Robert; Cher, Michael L; Polascik, Thomas J

Taha, Tarek; Tan, Wei Phin; Elshafei, Ahmed; Aminsharifi, Alireza; Given, Robert; Cher, Michael L; Polascik, Thomas J.

Afiliación

Taha T; Division of Urologic Surgery, Duke Cancer Institute, Durham, NC, USA.
Tan WP; Division of Urologic Surgery, Duke Cancer Institute, Durham, NC, USA.
Elshafei A; Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Aminsharifi A; Department of Urology, Medical School, Cairo University, Cairo, Egypt.
Given R; Division of Urologic Surgery, Duke Cancer Institute, Durham, NC, USA.
Cher ML; Department of Urology, Eastern Virginia Medical School, VA, USA.
Polascik TJ; Department of Urology, Wayne State University School of Medicine, Detroit, MI, USA.

Curr Urol ; 15(2): 79-84, 2021 Jun.

Article en En | MEDLINE | ID: mdl-34168524

Palabras clave

Conventional fixed-size ice probe; Cryotherapy; Prostate cancer; V-Probe®

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Urol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google